| Biochemical changes in blood of type 2 diabetes with and without metabolic syndrome and their association with metabolic syndrome components F Zadhoush, M Sadeghi, M Pourfarzam Journal of Research in Medical Sciences 20 (8), 763-770, 2015 | 49 | 2015 |
| IL-23 plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy subjects M Shajarian, F Alsahebfosoul, M Etemadifar, N Sedaghat, M Shahbazi, ... Immunological investigations 44 (1), 36-44, 2015 | 41 | 2015 |
| Interleukin-33 plasma levels in patients with relapsing-remitting multiple sclerosis F Alsahebfosoul, I Rahimmanesh, M Shajarian, M Etemadifar, ... Biomolecular concepts 8 (1), 55-60, 2017 | 29 | 2017 |
| Association of RBP4 gene variants with adverse lipid profile and obesity M Shajarian, L Rafiee, H Naji-Esfahani, S Haghjooy-Javanmard, S Nizal Gene 561 (1), 1-5, 2015 | 14 | 2015 |
| IL-27 plasma level in relapsing remitting multiple sclerosis subjects: The double-faced cytokine S Naderi, Z Hejazi, M Shajarian, F Alsahebfosoul, M Etemadifar, ... Journal of Immunoassay and Immunochemistry 37 (6), 659-670, 2016 | 12 | 2016 |
| The effect of IFN-β treatment on plasma levels of BDNF and IL-6 in relapsing-remitting multiple sclerosis patients M Shajarian, F Alsahebfosoul, M Etemadifar Neuroimmunomodulation 28 (3), 150-157, 2021 | 11 | 2021 |
| Inflammatory cytokines in relapsing-remitting multiple sclerosis (RRMS) patients M Shaharian, F Alsahebfosoul, M Etemadifar Multiple sclerosis and related disorders 3 (6), 741, 2014 | 2 | 2014 |
| Investigation of Oncostatin M protein expression in Iranian relapsing remitting multiple sclerosis patients P Alikhani, F Alsahebfosoul, M Shajarian Multiple sclerosis and related disorders 3 (6), 747, 2014 | 1 | 2014 |
| Corrigendum to: Interleukin-33 plasma levels in patients with relapsing-remitting multiple sclerosis F Alsahebfosoul, I Rahimmanesh, M Shajarian, M Etemadifar, ... Biomolecular Concepts 8 (5-6), 221-221, 2017 | | 2017 |
| Evaluation of plasma level of brain-derived neurotrophic factor and interleukin 6 in relapsing-remitting multiple sclerosis patients compared to healthy subjects M Shajarian, M Etemadifar, F Alsahebfosoul Multiple Sclerosis Journal 22 (6), Np19-Np19, 2016 | | 2016 |
| Osteopontin and Oncostatin M increase significantly in Iranian relapsing-remitting multiple sclerosis patients P Alikhani, F Alsahebfosoul, M Etemadifar, M Shajarian Multiple Sclerosis and Related Disorders 3 (6), 759-760, 2014 | | 2014 |
| Corrigendum to “Inflammatory cytokines in relapsing-remitting multiple sclerosis (RRMS) patients”[Mult. Scler. Relat. Disord. M Shajarian, F Alsahebfosoul, M Etemadifar | | |
| IL-23 Plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy M Shajarian, F Alsahebfosoul, M Etemadifar, N Sedaghat, M Shahbazi, ... | | |
